Sign up
Pharma Capital

Buds & Duds: Cannabis stocks blunted by widespread market woes

Duds of the day include Tilray Inc (NASDAQ:TLRY), Cronos Group Inc (NASDAQ:CRON). While the only bud of the day was 22nd Century Group Inc (NYSEAMERICAN:XXII). 


View full XXII profile View Profile
View All

© biotech Capital 2019

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.